FDA Alert: Clarithromycin Risky in Patients With Heart Disease FDA Alert: Clarithromycin Risky in Patients With Heart Disease

The agency adds a new warning about the increased risk for death in patients with heart disease prescribed the antibiotic clarithromycin and recommends considering an alternative when possible.News Alerts
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Cardiology News Alert Source Type: news